{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:27:31Z","timestamp":1784618851926,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-025-00766-1","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:10:41Z","timestamp":1763691041000},"page":"153-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intensive Versus Standard Blood Pressure Control in Type 2 Diabetes: Cardiovascular and Microvascular Outcomes"],"prefix":"10.1007","volume":"33","author":[{"given":"Ali","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9522-2385","authenticated-orcid":false,"given":"Muhammad Basil","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Alabdallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissy Valsan","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishnan","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"766_CR1","volume-title":"Hypertension","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Hypertension. Geneva: World Health Organization; 2021."},{"key":"766_CR2","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2021","unstructured":"International Diabetes Federation. IDF diabetes atlas. 10th ed. Brussels: International Diabetes Federation; 2021.","edition":"10th ed"},{"key":"766_CR3","volume-title":"Health survey for England 2019","author":"NHS Digital","year":"2020","unstructured":"NHS Digital. Health survey for England 2019. Leeds: NHS Digital; 2020."},{"key":"766_CR4","volume-title":"Diabetes: facts and stats","author":"Diabetes UK","year":"2019","unstructured":"Diabetes UK. Diabetes: facts and stats. London: Diabetes UK; 2019."},{"issue":"7160","key":"766_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","unstructured":"UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703\u201313. https:\/\/doi.org\/10.1136\/bmj.317.7160.703.","journal-title":"BMJ"},{"issue":"6","key":"766_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"B Williams","year":"2023","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2023 ESH guidelines for the management of arterial hypertension. J Hypertens. 2023;41(6):873\u2013981. https:\/\/doi.org\/10.1097\/HJH.0000000000003480.","journal-title":"J Hypertens"},{"issue":"17","key":"766_CR7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","volume":"362","author":"WC Cushman","year":"2010","unstructured":"Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al. Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1001286.","journal-title":"N Engl J Med"},{"issue":"6","key":"766_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2213-8587(17)30078-4","volume":"5","author":"K Ueki","year":"2017","unstructured":"Ueki K, Sasaki S, Araki E, Kadowaki T, Ito H, Sone H, et al. Impact of intensive multifactorial intervention on cardiovascular and microvascular outcomes in type 2 diabetes: the J-DOIT3 trial. Lancet Diabetes Endocrinol. 2017;5(6):427\u201336. https:\/\/doi.org\/10.1016\/S2213-8587(17)30078-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"15","key":"766_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1056\/NEJMoa2412006","volume":"392","author":"Y Xie","year":"2025","unstructured":"Xie Y, Zhang Z, Chen J, Liu W, Zhao H, Li F, et al. Comparison of intensive versus standard blood-pressure control on cardiovascular and renal outcomes in type 2 diabetes: the BPROAD trial. N Engl J Med. 2025;392(15):1234\u201345. https:\/\/doi.org\/10.1056\/NEJMoa2412006.","journal-title":"N Engl J Med"},{"issue":"14","key":"766_CR10","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1001\/jama.299.14.1620","volume":"299","author":"BV Howard","year":"2008","unstructured":"Howard BV, Roman MJ, Davis SN, Hsia J, Rodabough RJ, Bonds DE, et al. Effects of intensive versus standard lipid and blood-pressure targets on progression of atherosclerosis in American Indians with type 2 diabetes: the SANDS trial. JAMA. 2008;299(14):1620\u201331. https:\/\/doi.org\/10.1001\/jama.299.14.1620.","journal-title":"JAMA"},{"issue":"6","key":"766_CR11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/HYPERTENSIONAHA.118.12414","volume":"73","author":"F Rahman","year":"2019","unstructured":"Rahman F, McEvoy JW, Ohkuma T, Woodward M, Neal B, Salam A, et al. Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus. Hypertension. 2019;73(6):1291\u20139. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.12414.","journal-title":"Hypertension"},{"issue":"6","key":"766_CR12","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1161\/HYPERTENSIONAHA.115.06236","volume":"66","author":"EZ Soliman","year":"2015","unstructured":"Soliman EZ, Byington RP, Bigger JT, Evans G, Cushman WC, Cutler JA, et al. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus: the Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial. Hypertension. 2015;66(6):1242\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06236.","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"766_CR13","first-page":"B54","volume":"23","author":"RW Schrier","year":"2000","unstructured":"Schrier RW, Estacio RO, Jeffers BW, Johnson L, Bilsker M, Vicknair N, et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. Diabetes Care. 2000;23(Suppl 2):B54\u201364.","journal-title":"Diabetes Care"},{"issue":"12","key":"766_CR14","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.amjhyper.2006.05.011","volume":"19","author":"RO Estacio","year":"2006","unstructured":"Estacio RO, Jeffers BW, Gifford N, Schrier RW. Intensive blood pressure control with valsartan reduces urinary albumin excretion in normotensive patients with type 2 diabetes: the ABCD-2V trial. Am J Hypertens. 2006;19(12):1241\u20138.","journal-title":"Am J Hypertens"},{"issue":"4","key":"766_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/01.CIR.0000049640.46039.52","volume":"107","author":"PS Mehler","year":"2003","unstructured":"Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003;107(4):753\u20136. https:\/\/doi.org\/10.1161\/01.CIR.0000049640.46039.52.","journal-title":"Circulation"},{"issue":"21","key":"766_CR16","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","volume":"290","author":"CJ Pepine","year":"2003","unstructured":"Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, et al. A calcium antagonist versus non\u2013calcium antagonist hypertension treatment strategy for patients with coronary artery disease and diabetes mellitus (INVEST): a randomized controlled trial. JAMA. 2003;290(21):2805\u201316. https:\/\/doi.org\/10.1001\/jama.290.21.2805.","journal-title":"JAMA"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-025-00766-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-025-00766-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-025-00766-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T23:26:32Z","timestamp":1773530792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-025-00766-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1007\/s40292-025-00766-1","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is based on analysis of data extracted from published clinical trials. As no new patient data were collected, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This article complies with ethical standards. It is a meta-analysis of previously published randomized controlled trials; no new human or animal studies were conducted by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or Animal Studies"}}]}}